MGHbanner BulfinchBldg
MGH  Neurosurgical Service Home
MGH Neurosurgical Service
Massachusetts General HospitalHarvard Medical School

MGH Shield Hvd Med Sch Shield Partners Logo
Neurosurgery @ MGHPeople @ MGH NeurosurgeryClinical Centers @ MGH NeurosurgeryResearch @ MGH NSEducation @ MGH NeurosurgerySupport Groups @ MGH NeurosurgeryNews @ MGH NeurosurgeryReferrals @ MGH Neurosurgery
Selected Recent Publications
Robert L. Martuza, M.D., F.A.C.S. 
Dr Martuza | Research | CV | Links
[NIH NLM PubMed Search][NIH NLM PubMed Search] National Libraries of Medicine
National Institutes of Health
PubMed Search

Martuza Publications
Martuza Pubs 2008
Martuza Pubs 2007
Martuza Pubs 2006
Martuza Pubs 2005
Martuza Pubs 2004

Martuza Pubs 2003
Martuza Pubs 2002
Martuza Pubs 2001
Martuza Pubs 2000
Martuza Pubs 1999

"NOTICE: The PubMed data are for personal use only. Users are responsible for complying with all copyright and licensing restrictions associated with data."

Selected Recent Publications:

1 : Mashour GA, Martuza RL, Kurtz A.

Induction of melanogenic abnormalities in NF1+/- mutant mice by DMBA.
J Invest Dermatol. 1999 Dec;113(6):1133-4. No abstract available.
PMID: 10594763; UI: 20062994

2 : Todo T, Rabkin SD, Chahlavi A, Martuza RL.

Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy.
Hum Gene Ther. 1999 Nov 20;10(17):2869-78.
PMID: 10584932; UI: 20049627

3 : Todo T, Rabkin SD, Sundaresan P, Wu A, Meehan KR, Herscowitz HB, Martuza RL.

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus.
Hum Gene Ther. 1999 Nov 20;10(17):2741-55.
PMID: 10584921; UI: 20049616

4 : Walker JR, McGeagh KG, Sundaresan P, Jorgensen TJ, Rabkin SD, Martuza RL.

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207.
Hum Gene Ther. 1999 Sep 1;10(13):2237-43.
PMID: 10498254; UI: 99426542

5 : Miyatake SI, Tani S, Feigenbaum F, Sundaresan P, Toda H, Narumi O, Kikuchi H, Hashimoto N, Hangai M, Martuza RL, Rabkin SD.

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo.
Gene Ther. 1999 Apr;6(4):564-72.
PMID: 10476216; UI: 99405131

6 : Mashour GA, Wang HL, Cabal-Manzano R, Wellstein A, Martuza RL, Kurtz A.

Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1.
J Invest Dermatol. 1999 Sep;113(3):398-402.
PMID: 10469340; UI: 99398478

7 : Hunter WD, Martuza RL, Feigenbaum F, Todo T, Mineta T, Yazaki T, Toda M, Newsome JT, Platenberg RC, Manz HJ, Rabkin SD.

Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates.
J Virol. 1999 Aug;73(8):6319-26.
PMID: 10400723; UI: 99329150

8 : Toda M, Rabkin SD, Kojima H, Martuza RL.

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity.
Hum Gene Ther. 1999 Feb 10;10(3):385-93.
PMID: 10048391; UI: 99156136

9 : New KC, Gale K, Martuza RL, Rabkin SD.

Novel synthesis and release of GABA in cerebellar granule cell cultures after infection with defective herpes simplex virus vectors expressing glutamic acid decarboxylase.
Brain Res Mol Brain Res. 1998 Oct 30;61(1-2):121-35.
PMID: 9795182; UI: 99013981

10 : Toda M, Rabkin SD, Martuza RL.

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.
Hum Gene Ther. 1998 Oct 10;9(15):2177-85.
PMID: 9794202; UI: 99008304

11 : Toda M, Martuza RL, Kojima H, Rabkin SD.

In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity.
J Immunol. 1998 May 1;160(9):4457-64.
PMID: 9574551; UI: 98233695

12 : Martuza RL.

Act locally, think globally.
Nat Med. 1997 Dec;3(12):1323. No abstract available.
PMID: 9396599; UI: 98057306

13 : Miyatake S, Martuza RL, Rabkin SD.

Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma.
Cancer Gene Ther. 1997 Jul-Aug;4(4):222-8.
PMID: 9253507; UI: 97397468

14 : Miyatake S, Iyer A, Martuza RL, Rabkin SD.

Transcriptional targeting of herpes simplex virus for cell-specific replication.
J Virol. 1997 Jul;71(7):5124-32.
PMID: 9188579; UI: 97332345

15 : Menon AG, Rutter JL, von Sattel JP, Synder H, Murdoch C, Blumenfeld A, Martuza RL, von Deimling A, Gusella JF, Houseal TW.

Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.
Oncogene. 1997 Feb 6;14(5):611-6.
PMID: 9053860; UI: 97178854

16 : Yazaki T, Martuza RL, Rabkin SD.

Expression of L1 in primary astrocytes via a defective herpes simplex virus vector promotes neurite outgrowth and neural cell migration.
Brain Res Mol Brain Res. 1996 Dec 31;43(1-2):311-20.
PMID: 9037547; UI: 97189276

17 : Yazaki T, Ahmad S, Chahlavi A, Zylber-Katz E, Dean NM, Rabkin SD, Martuza RL, Glazer RI.

Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.
Mol Pharmacol. 1996 Aug;50(2):236-42.
PMID: 8700129; UI: 96319771

18 : Viola JJ, Martuza RL.

Gene therapies for glioblastomas.
Baillieres Clin Neurol. 1996 Jun;5(2):413-24. Review. No abstract available.
PMID: 8781280; UI: 96374898

19 : Yazaki T, Manz HJ, Rabkin SD, Martuza RL.

Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1.
Cancer Res. 1995 Nov 1;55(21):4752-6.
PMID: 7585498; UI: 96046565

20 : Mineta T, Rabkin SD, Yazaki T, Hunter WD, Martuza RL.

Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
Nat Med. 1995 Sep;1(9):938-43.
PMID: 7585221; UI: 96071601


Disclaimer About Medical Information: The information and reference materials contained herein is intended solely for the information of the reader. It should not be used for treatment purposes, but rather for discussion with the patient's own physician. All visitors to this and associated sites from the Neurosurgical Service at MGH agree to read and abide by the the complete terms of legal agreement found at the Neurosurgery "disclaimer & legal agreement." See also: the MGH Disclaimer, the MGH Privacy Policy, and the MGH Interactive Program Disclaimer - Copyright 2006.
MGH  Neurosurgical Service Home
Research@Neurosurgery Visitors must read the disclaimer - legal agreement.
All Rights Reserved. Copyright 20006 MGH Neurosurgical Service

(internal access only)
System Info Contact: WebServant or the PageServant or e-mail C.Owen